Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abvc Biopharma Inc
(NQ:
ABVC
)
0.7100
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
66
Open
0.7100
Bid (Size)
0.7100 (11)
Ask (Size)
0.7400 (3)
Prev. Close
0.7100
Today's Range
0.7100 - 0.7100
52wk Range
0.5000 - 3.130
Shares Outstanding
24,470,526
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference
January 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Performance
YTD
+18.33%
+18.33%
1 Month
+18.33%
+18.33%
3 Month
-10.87%
-10.87%
6 Month
+5.39%
+5.39%
1 Year
-72.37%
-72.37%
More News
Read More
What's happening With ABVC BioPharma Shares?
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
Via
Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 06, 2023
Via
InvestorPlace
Dow Falls Over 200 Points; Walgreens Earnings Top Expectations
January 05, 2023
Via
Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 05, 2023
Via
Benzinga
Nasdaq Down Over 100 Points; Crude Oil Rises 1%
January 05, 2023
Via
Benzinga
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
January 05, 2023
Via
NewMediaWire
Exposures
Product Safety
SEC Goes After 'MrZackMorris, 'Stock Sniper' For Alleged Fraud
December 14, 2022
Via
Benzinga
ABVC BioPharma Provides Vitargus Update - Phase II Vitargus Study Protocol Received Thai FDA Approval
November 17, 2022
Via
NewMediaWire
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via
Benzinga
ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results
November 14, 2022
Via
NewMediaWire
ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)
November 07, 2022
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma's Medication for Treating Depression in Cancer Patients
November 02, 2022
Via
NewMediaWire
ABVC BioPharma Announces Vitargus Phase II Study Plan Approved by HREC in Australia
October 05, 2022
Via
NewMediaWire
12 Health Care Stocks Moving In Friday's Intraday Session
September 23, 2022
Via
Benzinga
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
September 22, 2022
Via
NewMediaWire
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Via
Benzinga
ABVC Biopharma Announces Letter to Shareholders
September 13, 2022
Via
NewMediaWire
ABVC BioPharma Selects Additional Vitargus Phase II Study Site
September 09, 2022
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 23, 2022
Via
Benzinga
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
August 31, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.